Bullish option flow detected in BridgeBio Pharma with 6,190 calls trading, 7x expected, and implied vol increasing over 24 points to 113.85%. Apr-23 15 calls and Apr-23 17.5 calls are the most active options, with total volume in those strikes near 3,600 contracts. The Put/Call Ratio is 0.03. Earnings are expected on May 4th.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on BBIO:
- Here’s Why Investors Are Excited About BridgeBio (NASDAQ:BBIO) Stock
- BridgeBio attracting bigger companies’ takeover interest, Bloomberg says
- BridgeBio announces first patient dosed in Phase 1 trial of BBP-398 with OPDIVO
- BridgeBio Pharma Announces First Lung Cancer Patient Dosed in Phase 1 Trial for SHP2 Inhibitor BBP-398 in Combination with Bristol Myers Squibb’s OPDIVO® (nivolumab)
- BridgeBio Pharma Shares Preliminary Findings on Novel Bioassay Measuring Glycosylated Alpha-dystroglycan (⍺DG) in Patients with Limb-girdle Muscular Dystrophy Type 2I (LGMD2I)